TYSABRI - natalizumab
Navigation: NDC > Supplier starting with: E > ELAN PHARMACEUTICALS, INC.| Field | Value |
|---|---|
| NDC Code: | 59075-730 |
| Proprietary Name: | TYSABRI |
| Suffix: | |
| Non-Proprietary Name: | natalizumab |
| Dosage Form: | INJECTION |
| Method: | INTRAVENOUS |
| Original Marketing Date: | 23-11-2004 |
| Category Name: | BLA |
| Application Number: | BLA125104 |
| Labeler: | ELAN PHARMACEUTICALS, INC. |
| Substance Name: | NATALIZUMAB |
| Active Numerator Strength: | 300 |
| Active Ingredient Unit: | mg/15mL |
| Pharm Classes: | Integrin Receptor Antagonist [EPC],Integrin Receptor Antagonists [MoA] |
| DEA Schedule: |